MDK-271

N/A

Report date: 2025/01/03 11:19:09

Base Information

Drug NameMDK-271
Drug Alias NameMDK-271MKD-271
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein
Mechanisms of ActionInterleukin-2 receptor beta chain agonistsInterleukin-7 receptors agonistsInterleukin-15 receptors agonists
TargetsInterleukin-2 receptor beta chainInterleukin-7 receptorsInterleukin-15 receptors
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMedikine Inc
China Registration ClassN/A

Develop Information

Active CompaniesMedikine Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A